RR

Rupesh Ratnakar Yeola

Active Director Director DIN 07437982
DIN 07437982 First appointment Apr 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2016
Shareholding value •••• Premium profile

About Rupesh Ratnakar Yeola

Data last updated:

Rupesh Ratnakar Yeola is a Director at Innovativ Biosciences Private Limited (since 2016). The company operates in Healthcare. Innovativ Biosciences Private Limited reported revenue of ₹1.59 Cr (FY 2025).

DIN 07437982
Primary Designation Director
Industry Healthcare
First Appointment 28 Apr 2016
Oldest Company Age 10 yrs
Largest company Innovativ Biosciences Private Limited · ₹1.59 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20162016₹1.59 Cr (FY 2025)Active

Board colleagues of Rupesh Ratnakar Yeola

NameDINCompanyDesignation
Shraddha Rupesh Yeola08029497Innovativ Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Innovativ Biosciences Private Limited
Premium access

Shareholding and investment profile for Rupesh Ratnakar Yeola

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupesh Ratnakar Yeola

Rupesh Ratnakar Yeola currently holds 1 directorship: Innovativ Biosciences Private Limited (Director, since 28 Apr 2016, revenue ₹1.59 Cr (FY 2025)).

Rupesh Ratnakar Yeola was first appointed on 28 Apr 2016 as Director at Innovativ Biosciences Private Limited.

The current boards of Rupesh Ratnakar Yeola's companies include Shraddha Rupesh Yeola (Innovativ Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available